Redx Pharma is a clinical-stage biotechnology company focused on discovering and developing novel, small-molecule targeted medicines for cancer and fibrotic diseases. Its research and development capabilities span medicinal chemistry, biology, and clinical development, with lead programs including the selective ROCK2 inhibitor zelasudil for idiopathic pulmonary fibrosis.
Leadership & Board
Current Number of Employees36
Current LinkedIn Followers12,924
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$36M
Total Amount Raised$36M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$36M
Latest Funding Amount$36M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.